Director John James O'Connor filed a statement of changes in beneficial ownership with the SEC on November 20, 2026, reporting the exercise of stock options in LeMaitre Vascular, Inc. on November 18, 2026.
Key Highlights
- Reporting person: John James O'Connor, identified as a director of LeMaitre Vascular, Inc.
- Transaction: O'Connor acquired 3,444 shares of common stock via an option exercise (transaction code M) on November 18, 2026.
- Exercise price: The stock option carried an exercise price of $48.60 per share.
- Option details: The exercised stock option was described as fully vested and exercisable, with an expiration date of December 11, 2026, and an original grant date of December 11, 2021.
- Resulting ownership: Following the transaction, O'Connor directly held 66,271 shares of LeMaitre Vascular common stock.
- Remaining derivative holdings: O'Connor held zero stock options following the reported exercise.
O'Connor's November 2026 Option Exercise at LeMaitre Vascular
According to the filing, John James O'Connor, a director of LeMaitre Vascular, Inc. (NASDAQ:LMAT), exercised a stock option covering 3,444 shares of common stock on November 18, 2026. The transaction was recorded under code M, indicating an exercise of an in-the-money or at-the-money option or conversion of a derivative security. The exercise price was $48.60 per share, and the filing states the price of the derivative security was $0, consistent with a standard option exercise.
The filing notes in its explanation of responses that the shares reported in Table I "represent shares acquired upon exercise of options by the Reporting Person, as reported in Table II," and that "this option is fully vested and exercisable." The option had been granted on December 11, 2021, and carried an expiration date of December 11, 2026, making the November 18, 2026 exercise approximately three weeks before expiration. Following the transaction, O'Connor held no remaining stock options in Table II, and his direct beneficial ownership of LeMaitre Vascular common stock stood at 66,271 shares. LeMaitre Vascular is a medical device company focused on the vascular surgery market, and O'Connor's address of record is listed as the company's Burlington, Massachusetts headquarters.
What Was Disclosed
The filing reported that director John James O'Connor exercised 3,444 fully vested LeMaitre Vascular stock options at $48.60 per share on November 18, 2026, bringing his total direct common stock holdings to 66,271 shares with no remaining options outstanding.



Please wait processing your request...